Medical Xpress news

Medical Xpress / Study finds cystic fibrosis drug allows patients to safely scale back lung therapies

A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy elexacaftor/tezacaftor/ivacaftor (ETI) can safely reduce many of their daily lung treatments ...

Dec 5, 2025 in Medications
Medical Xpress / Memories are not static: How the brain stores and reshapes personal experiences over time

A study from the University of East Anglia is helping scientists better understand how our brains remember past events—and how those memories can change over time.

Dec 5, 2025 in Psychology & Psychiatry
Medical Xpress / Tricking the brain to make exercise feel easier

Why do some people find a short jog exhausting, while others seem to run effortlessly? Of course, part of the answer lies in training and muscle strength. But the brain also plays a role, particularly in how we perceive effort.

Dec 5, 2025 in Neuroscience
Medical Xpress / Study linking tenascin-C protein to muscle stem cell levels and muscle regeneration may lead to treatment for frailty

As we age, the muscles we rely on for daily activities tend to become less reliable. With enough decline, even normal movements such as getting out of bed become risky.

Medical Xpress / Saliva and plasma at the core of cancer detection and treatment

Saliva and plasma could be crucial in detecting recurrences or relapses of head and neck cancers, negating the need for a painful and invasive biopsy.

Dec 5, 2025 in Oncology & Cancer
Medical Xpress / Innovative drug delivery mechanism triggered by cooling could provide targeted pain relief

Leon Bellan, associate professor of mechanical and biomedical engineering at Vanderbilt, and his team have developed a novel cooling-triggered device that could allow patients to safely and conveniently receive drugs for ...

Dec 5, 2025 in Medications
Medical Xpress / Beyond biology: Why social context is the key for improving modern medicine

A new series in The Lancet led by a UC Berkeley professor equips policymakers and clinicians with a toolkit to break out of silos and make more informed health decisions.

Medical Xpress / Genetic testing reveals often-overlooked fungal infections in California clinics

A new study reveals that a rarely-diagnosed and frequently drug-resistant species, Aspergillus tubingensis, may be one of the most common causes of fungal infections in Southern California.

Dec 5, 2025 in Medical research
Medical Xpress / Genetic variant may explain why some children with myocarditis develop heart failure

A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk of developing heart failure, which can be fatal, according to a study published in Circulation ...

Dec 5, 2025 in Genetics
Medical Xpress / Comprehensive map reveals neuronal dendrites in the mouse brain in greater detail

Understanding the shape or morphology of neurons and mapping the tree-like branches via which they receive signals from other cells (i.e., dendrites) is a long-standing objective of neuroscience research. Ultimately, this ...

Dec 4, 2025 in Genetics
Medical Xpress / Antibody halts triple-negative breast cancer in preclinical models

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with ...

Dec 4, 2025 in Oncology & Cancer
Medical Xpress / Single enzyme failure found to drive neuron loss in dementia

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. The study provides ...

Dec 4, 2025 in Neuroscience